The Boston Scientific Charger Balloon Catheter (REF H74939206120870) is an over-the-wire percutaneous transluminal angioplasty (PTA) balloon dilatation catheter configured with a 12 mm balloon diameter and an 80 mm balloon working length. It is engineered to deliver controlled radial dilatation force in larger peripheral vessels while maintaining a low crossing profile and reliable rewrap performance for multiple inflations.
Key Features
- Balloon diameter: 12 mm
- Balloon length: 80 mm
- Catheter design: Over-the-wire (OTW) PTA balloon dilatation catheter
- Guidewire compatibility: 0.035 inch guidewire lumen
- Non-compliant / semi-compliant behavior: Engineered for predictable diameter at nominal and rated burst pressures
- Radiopaque markers: Two markers identify balloon working length under fluoroscopy
- Hydrophilic-style shaft transition: Supports trackability and pushability through tortuous anatomy
- Usable / working length: Not specified in the located sources
- Nominal and rated burst pressures: Not specified in the located sources
- Sheath compatibility: Not specified in the located sources
Clinical Applications
- Balloon dilatation of stenotic lesions in the peripheral vasculature, including iliac, femoral and other large-caliber peripheral arteries as indicated by the operating physician
- Post-dilatation of self-expanding or balloon-expandable stents in compatible vessel diameters
- Treatment of obstructive lesions of native or synthetic arteriovenous dialysis access fistulae where indicated
- Use only in accordance with the manufacturer's Instructions for Use (IFU) and approved indications in the destination market
Product Information
- Brand: Boston Scientific
- Product line: Charger PTA Balloon Catheter
- Category: Peripheral Balloon Catheters
- REF / UPN: H74939206120870
- Configuration: 12 mm x 80 mm, over-the-wire
- Packaging: Single use, sterile (EO); refer to package labeling for expiry and lot
- Storage: Store in a cool, dry place away from direct sunlight
- Regulatory status: Refer to local labeling and IFU for approved indications and market availability